Skip to content

Omission of breast surgery for PredicTed pCR patients wIth MRI and vacuum-assisted bIopsy in breaST cancer after neoadjuvant chemotherapy: a multicenter, single-arm, non-inferiority trial [OPTIMIST trial]

Omission of breast surgery for PredicTed pCR patients wIth MRI and vacuum-assisted bIopsy in breaST cancer after neoadjuvant chemotherapy: a multicenter, single-arm, non-inferiority trial [OPTIMIST trial]

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007638
Enrollment
533
Registered
2022-08-09
Start date
2022-09-01
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : For patients who are expected to achieve pathologic complete response after neoadjuvant chemothearpy based on MRI findings, we will proceed vacuum-assisted biopsy of the main prima

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Sex: female Age: 20 years and older Patients with no clinical/radiologic distant metastasis Tumor type: Invasive ductal carcinoma Tumor subtype: HER2 positive(including luminal B type, triple negative Extent of disease: initial tumor size = 5cm, cN0-2 Patients with measurable tumor size Patients who are expected to achieve pCR after neoadjuvant chemotherapy (MRI size = 1.0 cm AND L-to-B SER = 1.6) Patients with clip inserted to the primary tumor site before or during neoadjuvant chemotherapy Patients with informed consent who are competent to make a voluntary decision

Exclusion criteria

Exclusion criteria: Multifocal lesion (=2) Extent of residual microcalcification after neoadjuvant chemotherapy > 2cm Bilateral breast cancer or inflammatory breast cancer Contraindication to radiotherapy History of previous contralateral breast cancer Breast cancer patients with distant metastasis Allergic history to MRI contrast Male breast cancer Patients incapable of giving informed consent owing to poor general conditions Patients with BRCA mutation Patients willing to receive breast surgery Patients with a history of cancer diagnosis within 5 years (However, skin cancer other than melanoma and breast carcinoma in situ other than ductal carcinoma in situ can be registered even if 5 years have not passed since the diagnosis)

Design outcomes

Primary

MeasureTime frame
Disease-Free Survival

Secondary

MeasureTime frame
Ipsilateral Breast Tumor Recurrence-Free Survival;Overall Survival ;Invasive Disease-Free Survival ;QoL, symptoms, and medical cost;Rate of residual axillary lymph node metastasis on axillary surgery

Countries

Korea, Republic of

Contacts

Public ContactHong Kyu Kim

Seoul National University Hospital

limittango@gmail.com+82-2-2072-2980

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 7, 2026